Skip to content

Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome

Team-based Interventional Triage in Acute Coronary Syndrome Based on Non-Invasive Computed Tomography Coronary Angiography - a Randomized Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06101862
Acronym
TRACTION
Enrollment
2300
Registered
2023-10-26
Start date
2023-10-01
Completion date
2036-10-01
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction (AMI), Angina Pectoris, Unstable, Coronary Artery Disease, Coronary Disease, Coronary Stenoses, Diagnostic Imaging, Heart Attack, Ischemic Heart Disease, Multidetector Computed Tomography, Non STEMI, Percutaneous Coronary Intervention, Randomized Controlled Trial

Keywords

Angiography, Computed Tomography, Coronary, Non-STEACS, CCTA, ICA, Randomized, Interventional Triage, TRACTION, Diagnostic imaging, Interventional cardiology, VERDICT, CT, Coronary Angiography, Complications, Coronary CT-team, Ischemic heart disease, Acute myocardial infarction, Non-ST-elevation myocardial infarction (NSTEMI), Unstable angina pectoris, Percutaneous coronary intervention, Coronary artery bypass grafting, PCI, CABG, Diagnostic procedure, Interhospital transfers, Myocardial Ischemia

Brief summary

Coronary computed tomography angiography (CCTA) is a widely accepted initial diagnostic test for individuals suspected of having chronic coronary syndromes. However, there is limited evidence supporting its use in the acute setting. So far, no large-scale randomized trial has examined the performance of CCTA as an alternative to invasive coronary angiography (ICA) in individuals with non-ST-segment elevation myocardial infarction (NSTEACS). If CCTA were to replace ICA as a routine procedure for individuals with NSTEACS, it could reduce the risk of complications related to ICA, improve patient comfort, expedite decision-making, and reduce healthcare expenses and interhospital transfers.

Interventions

PROCEDURECCTA

Participants will be examined with CCTA during admission.

PROCEDUREConventional ICA

Patients will be examined with conventional standard-of-care ICA.

OTHERTeam-based interventional triage

The CCTA will be discussed at a coronary CT-team conference to establish the treatment strategy and provide guidance for any necessary interventional procedure.

Sponsors

University of Copenhagen
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Admitted with non-ST-segment elevation myocardial infarction or unstable angina pectoris and an indication for subacute ICA * Elevated troponin or ischemic electrocardiographic changes * Written informed consent

Exclusion criteria

* Instability requiring acute or emergent ICA * History of percutaneous coronary intervention or coronary artery bypass grafting * Estimated glomerular filtration rate < 30 mL/min/1.73m2 * Probable type 2 acute myocardial infarction * Severe valvular heart disease as primary diagnosis or potential need for valve intervention * History of spontaneous coronary artery dissection * Expected poor quality of the CCTA * Prior CCTA or ICA during index admission or within 1 week * Known allergy to beta-blockers or contrast agent * Pregnant or nursing * Previously randomized in this trial

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with a combined endpoint of major adverse cardiac eventsAt 1 year.All-cause mortality, non-fatal myocardial infarction, hospitalization with refractory angina, or hospitalization with heart failure.

Secondary

MeasureTime frameDescription
Number of participants with cardiovascular deathAt 1 year.
Number of participants with unplanned coronary revascularizationAt 1 year.
Health-related Quality of lifeAt 1 year.Measured by EQ-5D-5L
Number of participants with a the individual composites of the primary outcomeAt 1 year.All-cause mortality, non-fatal myocardial infarction, hospitalization with refractory angina, or hospitalization with heart failure.
Total (cumulative) radiation dosage during index admissionAt 1st hospital discharge, an average of 2 days.
Length of index hospitalizationAt 1st hospital discharge, an average of 2 days.
Angina symptom burdenAt 1 year.Measured by Seattle Angina Questionnaire

Countries

Denmark

Contacts

Primary ContactNiels Thue Olsen, PhD
niels.thue.olsen@regionh.dk+45 38 68 38 68

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026